Deutsch English Français

Contact

EP0995751

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP0995751

EP0995751 - Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 12.05.2006 Database last updated on 16.07.2024
Most recent event Tooltip	20.04.2007	Lapse of the patent in a contracting state New state(s): CY, LU	published on 23.05.2007 [2007/21]
Applicant(s)	For:AT BE CH DE DK ES FI FR GR IE IT LI LU MC NL CY PT SE Pfizer Inc. 235 East 42nd Street New York, NY 10017 / US
	For:GB Pfizer Limited Ramsgate Road Sandwich, Kent CT13 9NJ / GB
	[N/P]
Former [2005/26]	For:AT BE CH DE DK ES FI FR GR IE IT LI LU MC NL CY PT SE PFIZER INC. 235 East 42nd Street New York, N.Y. 10017 / US
	For:GB Pfizer Limited Ramsgate Road Sandwich, Kent CT13 9NJ / GB
Former [2000/17]	For:AT BE CH DE DK ES FI FR GR IE IT LI LU MC NL CY PT SE PFIZER INC. 235 East 42nd Street New York, N.Y. 10017 / US
	For:GB Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJ / GB
Inventor(s)	01 / Bunnage, Mark Edward, Pfizer Central Research Ramsgate Road Sandwich, Kent CT13 9NJ / GB
	02 / Street, Stephen Derek Albert, Pfizer Central Res. Ramsgate Road Sandwich, Kent CT13 9NJ / GB
	03 / Mathias, John Paul, Pfizer Central Research Ramsgate Road Sandwich, Kent CT13 9NJ / GB
	04 / Wood, Anthony, Pfizer Central Research Ramsgate Road Sandwich, Kent CT13 9NJ / GB
	[2000/17]
Representative(s)	Edwards, Fiona Anne Pfizer Limited, UK Patents Department, Ramsgate Road Sandwich Kent CT13 9NJ / GB
	[N/P]
Former [2005/23]	Edwards, Fiona Anne Pfizer Limited, UK Patents Department, Ramsgate Road Sandwich, Kent CT13 9NJ / GB
Former [2000/17]	McNeeney, Stephen Phillip Eric Potter Clarkson, Park View House, 58 The Ropewalk Nottingham NG1 5DD / GB
Application number, filing date	99308158.7	15.10.1999
	[2000/17]
Priority number, date	GB19980023103	23.10.1998 Original published format: GB 9823103
	[2000/17]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	EP0995751
	Date:	26.04.2000
	Language:	EN
	[2000/17]
	Type:	A3 Search report
	No.:	EP0995751
	Date:	18.10.2000
	[2000/42]
	Type:	B1 Patent specification
	No.:	EP0995751
	Date:	29.06.2005
	Language:	EN
	[2005/26]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	30.08.2000
Classification	IPC:	C07D487/04, A61K31/506, C07D231/14, C07D401/12, // (C07D487/04, 239:00, 213:00)	[2000/17]
	CPC:	C07D487/04 (EP,US); A61P1/00 (EP); A61P11/00 (EP); A61P11/06 (EP); A61P13/00 (EP); A61P13/08 (EP); (+) A61P13/10 (EP); A61P15/10 (EP); A61P17/00 (EP); A61P17/06 (EP); A61P17/14 (EP); A61P25/00 (EP); A61P25/28 (EP); A61P27/06 (EP); A61P35/04 (EP); A61P43/00 (EP); A61P9/00 (EP); A61P9/10 (EP); A61P9/12 (EP) (-)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2000/17]
Title	German:	Pyrazolopyrimidinone cGMP PDE5 Inhibitoren zur Behandlung der sexuellen Dysfunktion	[2000/17]
	English:	Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction	[2000/17]
	French:	Inhibiteurs de cGMP PDE5 de pyrazolopyrimidinone servant à traiter le dysfonctionnement sexuel	[2000/17]
Examination procedure	03.11.2000	Examination requested [2001/01]
	26.03.2003	Despatch of a communication from the examining division (Time limit: M04)
	25.07.2003	Reply to a communication from the examining division
	29.09.2004	Date of oral proceedings
	15.10.2004	Minutes of oral proceedings despatched
	17.12.2004	Communication of intention to grant the patent
	27.04.2005	Fee for grant paid
	27.04.2005	Fee for publishing/printing paid
Opposition(s)	30.03.2006	No opposition filed within time limit [2006/24]
Fees paid	Renewal fee
	11.10.2001	Renewal fee patent year 03
	07.10.2002	Renewal fee patent year 04
	14.10.2003	Renewal fee patent year 05
	14.10.2004	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AT	29.06.2005
	BE	29.06.2005
	CH	29.06.2005
	FI	29.06.2005
	LI	29.06.2005
	NL	29.06.2005
	DK	29.09.2005
	GR	29.09.2005
	SE	29.09.2005
	CY	15.10.2005
	LU	31.10.2005
	MC	31.10.2005
	PT	07.12.2005
	[2007/21]
Former [2006/30]	AT	29.06.2005
	BE	29.06.2005
	CH	29.06.2005
	FI	29.06.2005
	LI	29.06.2005
	NL	29.06.2005
	DK	29.09.2005
	GR	29.09.2005
	SE	29.09.2005
	MC	31.10.2005
	PT	07.12.2005
Former [2006/26]	AT	29.06.2005
	BE	29.06.2005
	CH	29.06.2005
	FI	29.06.2005
	LI	29.06.2005
	NL	29.06.2005
	DK	29.09.2005
	GR	29.09.2005
	SE	29.09.2005
	PT	07.12.2005
Former [2006/22]	AT	29.06.2005
	BE	29.06.2005
	CH	29.06.2005
	FI	29.06.2005
	LI	29.06.2005
	NL	29.06.2005
	GR	29.09.2005
	SE	29.09.2005
	PT	07.12.2005
Former [2006/14]	AT	29.06.2005
	BE	29.06.2005
	CH	29.06.2005
	FI	29.06.2005
	LI	29.06.2005
	GR	29.09.2005
	SE	29.09.2005
	PT	07.12.2005
Former [2006/13]	AT	29.06.2005
	BE	29.06.2005
	FI	29.06.2005
	SE	29.09.2005
Former [2005/52]	FI	29.06.2005
	SE	29.09.2005
Former [2005/50]	SE	29.09.2005
Documents cited:	Search	[YX]JPH08253484 ;
		[XDY]WO9307149 (PFIZER LTD [GB], et al) [XD] 1-16 * see examples 2 and 10 ; column W [Y] 19,20;
		[Y]WO9400453 (PFIZER LTD [GB], et al) [Y] 1-16,19,20 * column W *;
		[Y]WO9428902 (PFIZER LTD [GB], et al) [Y] 1-16,19,20 * column W *;
		[YX]EP0636626 (GLAXO LAB SA [FR]) [Y] 1-16,19,20 * see page 7, formula II ; column W [X] 17,18;
		[XDY]WO9616657 (PFIZER LTD [GB], et al) [XD] 1-16 * see page 9, 5th ex. ; column W [Y] 19,20;
		[Y]WO9628448 (SANOFI WINTHROP INC [US]) [Y] 1-16 * column W *;
		[Y]WO9628429 (SANOFI WINTHROP INC [US]) [Y] 1-16 * column W *;
		[Y]EP0812845 (PFIZER LTD [GB], et al) [Y] 17,18 * see page 5 ,scheme, ex. (II) ; column W ;
		[PX]WO9849166 (PFIZER LTD [GB], et al) [PX] 1-16,19,20,17,18 * see page 11, cpd. (VI); page 13, cpds. (IXA), (IXB) ; column W ;
		[E]WO9954333 (PFIZER [US], et al) [E] 1-20* column W *;
		[Y] - DUMAITRE B ET AL, "SYNTHESIS AND CYCLIC GMP PHOSPHODIESTERASE INHIBITORY ACTIVITY OF A SERIES OF 6-PHENYLPYRAZOLO- 3,4-DIHYDRO-PYRIMIDONES", JOURNAL OF MEDICINAL CHEMISTRY,US,AMERICAN CHEMICAL SOCIETY. WASHINGTON, (19960101), vol. 39, no. 8, ISSN 0022-2623, pages 1635 - 1644, XP002024856 [Y] 1-16 * column W * DOI: http://dx.doi.org/10.1021/jm950812j
		[YX] - PATENT ABSTRACTS OF JAPAN, (19970228), vol. 1997, no. 02, & JP08253484 A 19961001 (TAISHO PHARMACEUT CO LTD) [Y] 1-16 * abstract * [X] 17,18
		[Y] - TERRETT N K ET AL, "Sildenafil (VIAGRA), a potent and selective inhibitor of type 5 CGMP phosphodiesterase with utility for the treatment of male erectile dysfunction", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,GB,OXFORD, (19960806), vol. 6, no. 15, ISSN 0960-894X, pages 1819 - 1824, XP004135609 [Y] 1-16,19,20,17,18 * see p.1823,, ex. 5 ; column W DOI: http://dx.doi.org/10.1016/0960-894X(96)00323-X

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p